BD Diagnostics Revenue Up 3% In Fiscal First Quarter, But Medical Sales Fall
This article was originally published in The Gray Sheet
Executive Summary
BD's diagnostics revenue rose 3.3% to $540.1 million in the firm's fiscal first quarter, aided by sales of safety-engineered products, cancer tests and infectious disease assays, the firm reported Jan. 28